Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
127,672
Value
$63.4M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026127,672$63.4M<0.1%+18,148+16.6%AddedHolders
Q1 2026109,524$48.9M<0.1%+9,011+9.0%AddedHolders
Q4 2025100,513$45.6M<0.1%+5,649+6.0%AddedHolders
Q3 202594,864$37.2M<0.1%+7,690+8.8%AddedHolders
Q2 202587,174$38.8M<0.1%−1,666−1.9%ReducedHolders
Q1 202588,840$43.1M<0.1%+9,370+11.8%AddedHolders
Q4 202479,470$32.0M<0.1%−997−1.2%ReducedHolders
Q3 202480,467$37.4M<0.1%+1,350+1.7%AddedHolders
Q2 202479,117$37.1M<0.1%+3,998+5.3%AddedHolders
Q1 202475,119$31.4M<0.1%+1,883+2.6%AddedHolders
Q4 202373,236$29.8M0.1%−48,292−39.7%ReducedHolders
Q3 2023121,528$42.3M0.1%+52,243+75.4%AddedHolders
Q2 202369,285$24.4M<0.1%+2,589+3.9%AddedHolders
Q1 202366,696$21.0M<0.1%+1,236+1.9%AddedHolders
Q4 202265,460$18.9M<0.1%+56,673+645.0%AddedHolders
Q3 20228,787$2.54M<0.1%−4,318−32.9%ReducedHolders
Q2 202213,105$3.69M<0.1%+7,280+125.0%AddedHolders
Q1 20225,825$1.52M<0.1%−683−10.5%ReducedHolders
Q4 20216,508$1.43M<0.1%−32,516−83.3%ReducedHolders
Q3 202139,024$7.08M<0.1%+6,914+21.5%AddedHolders
Q2 202132,110$6.47M<0.1%+25,348+374.9%AddedHolders
Q1 20216,762$1.45M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.